OSR Holdings Grants BCME Exclusive Global VXM01 Rights
TipRanks (Thu, 30-Apr 1:29 PM ET)
Market Chameleon (Thu, 30-Apr 6:29 AM ET)
OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026
ACCESS Newswire (Thu, 30-Apr 9:15 AM ET)
OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe
ACCESS Newswire (Wed, 29-Apr 9:50 AM ET)
OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note
ACCESS Newswire (Thu, 9-Apr 9:15 AM ET)
Presenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live stream
Globe Newswire (Wed, 1-Apr 7:00 AM ET)
Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream
Globe Newswire (Tue, 31-Mar 7:00 AM ET)
OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026
ACCESS Newswire (Mon, 30-Mar 9:00 AM ET)
ACCESS Newswire (Fri, 27-Mar 9:00 AM ET)
OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level
ACCESS Newswire (Mon, 23-Mar 8:38 AM ET)
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.
Osr Holdings trades on the NASDAQ stock market under the symbol OSRH.
As of May 1, 2026, OSRH stock price declined to $0.64 with 8,254,809 million shares trading.
OSRH has a beta of 1.62, meaning it tends to be more sensitive to market movements. OSRH has a correlation of 0.05 to the broad based SPY ETF.
OSRH has a market cap of $16.34 million. This is considered a Sub-Micro Cap stock.
Last quarter Osr Holdings reported $381,269 in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-380,001 and missed earnings estimates by -$.06.
The top ETF exchange traded funds that OSRH belongs to (by Net Assets): VXF.
OSRH has underperformed the market in the last year with a return of -52.8%, while SPY returned +31.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in OSRH shares. However, OSRH has outperformed the market in the last 3 month and 2 week periods, returning +9.0% and +15.5%, while SPY returned +4.4% and +2.7%, respectively. This indicates OSRH has been having a stronger performance recently.
OSRH support price is $.64 and resistance is $.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSRH shares will trade within this expected range on the day.
